In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of Molina Healthcare Inc (NYSE: MOH) closed at $162.72 in the last session, up 0.26% from day before closing price of $162.3. In other words, the price has increased by $0.26 from its previous closing price. On the day, 1.34 million shares were traded. MOH stock price reached its highest trading level at $164.015 during the session, while it also had its lowest trading level at $159.61.
Ratios:
We take a closer look at MOH’s different ratios to gain a better understanding of the stock. In the meantime, Its Debt-to-Equity ratio is 0.92 whereas as Long-Term Debt/Eq ratio is at 0.92.
On October 16, 2025, TD Cowen Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $203.
On October 14, 2025, Goldman started tracking the stock assigning a Neutral rating and target price of $207.Goldman initiated its Neutral rating on October 14, 2025, with a $207 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 24 ’25 when Schapiro Richard M sold 357 shares for $143.02 per share. The transaction valued at 51,058 led to the insider holds 11,352 shares of the business.
Schapiro Richard M bought 357 shares of MOH for $50,536 on Nov 24 ’25. On Aug 06 ’25, another insider, ROMNEY RONNA, who serves as the Director of the company, sold 700 shares for $153.74 each. As a result, the insider received 107,618 and left with 17,131 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MOH now has a Market Capitalization of 8819424256 and an Enterprise Value of 3768807936. As of this moment, Molina’s Price-to-Earnings (P/E) ratio for their current fiscal year is 10.09, and their Forward P/E ratio for the next fiscal year is 11.69. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.19 while its Price-to-Book (P/B) ratio in mrq is 1.98. Its current Enterprise Value per Revenue stands at 0.088 whereas that against EBITDA is 2.587.
Stock Price History:
The Beta on a monthly basis for MOH is 0.48, which has changed by -0.44932652 over the last 52 weeks, in comparison to a change of 0.13329959 over the same period for the S&P500. Over the past 52 weeks, MOH has reached a high of $359.97, while it has fallen to a 52-week low of $133.40. The 50-Day Moving Average of the stock is 1.78%, while the 200-Day Moving Average is calculated to be -29.53%.
Shares Statistics:
According to the various share statistics, MOH traded on average about 1.64M shares per day over the past 3-months and 1436410 shares per day over the past 10 days. A total of 51.00M shares are outstanding, with a floating share count of 50.79M. Insiders hold about 1.20% of the company’s shares, while institutions hold 113.24% stake in the company. Shares short for MOH as of 1764288000 were 4386502 with a Short Ratio of 2.67, compared to 1761868800 on 3140447. Therefore, it implies a Short% of Shares Outstanding of 4386502 and a Short% of Float of 11.359999.
Earnings Estimates
. The current rating of Molina Healthcare Inc (MOH) reflects the combined expertise of 17.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is $4.36, with high estimates of $6.11 and low estimates of $4.03.
Analysts are recommending an EPS of between $14.26 and $13.34 for the fiscal current year, implying an average EPS of $13.92. EPS for the following year is $15.22, with 17.0 analysts recommending between $16.44 and $14.0.
Revenue Estimates
According to 12 analysts,. The current quarter’s revenue is expected to be $11.05B. It ranges from a high estimate of $11.29B to a low estimate of $10.81B. As of. The current estimate, Molina Healthcare Inc’s year-ago sales were $10.5BFor the next quarter, 12 analysts are estimating revenue of $11.62B. There is a high estimate of $12.19B for the next quarter, whereas the lowest estimate is $11.47B.
A total of 14 analysts have provided revenue estimates for MOH’s current fiscal year. The highest revenue estimate was $45.34B, while the lowest revenue estimate was $44.86B, resulting in an average revenue estimate of $45.1B. In the same quarter a year ago, actual revenue was $40.65BBased on 14 analysts’ estimates, the company’s revenue will be $46.99B in the next fiscal year. The high estimate is $48.42B and the low estimate is $46.04B.
